Cure My Disease

Don't miss your cure!

 Log in / Sign up

Donor immune cells offer new hope for kids with tough leukemia

NCT ID NCT06080191

Recruiting now Disease control Sponsor: Bambino Gesù Hospital and Research Institute Source: ClinicalTrials.gov ↗

First seen Jan 09, 2026 · Last updated May 15, 2026 · Updated 24 times

Summary

This early-stage trial tests a new treatment for children and young adults with B-cell acute lymphoblastic leukemia that has come back or not responded to standard therapy. The treatment uses specially engineered immune cells from a healthy donor to target and kill cancer cells. The main goals are to check safety, find the right dose, and see if it works. About 24 participants will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ospedale Pediatrico Bambino Gesù

    RECRUITING

    Rome, Italy, 00165, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA